January 17, 2025
Pharmaceutical and biotechnology companies carry the responsibility of advancing scientific innovation, including navigating research, development, and commercialization. One of the most important, yet resource-intensive, functions between research and product launch is Medical Affairs, which focuses on evidence generation, stakeholder engagement, and communicating clinical data. However, hiring a full-time Medical Affairs team can be costly or inefficient, especially for early-stage or pre-commercial companies. This is where a biotech consulting firm becomes a strategic partner.
At BioLogic Pharma Solutions, a specialized biotech consulting firm, we offer a Fractional Medical Affairs™ consulting team that allows our clients to easily scale up or down as needed while receiving the support and strategy equivalent to full-time employees. We ensure our high-impact support aligns with our client’s current stage, goals, and budget by drawing on “fractional” time commitments of individual contributors across specialties within the BioLogic team. Our services typically include:
- Access to experienced Medical Affairs professionals across multiple therapeutic areas
- Strategic support for clinical development, launch planning, and scientific communications
- Congress planning and execution, including booth support, KOL engagement, and post-congress follow-up
- Project-based support including field medical deployment and advisory board coordination
- Medical communications and publications planning
- Cross-functional coordination to support compliance and launch readiness
Understanding a Fractional Medical Affairs™ Consulting Team
Our Medical Affairs consultants gives pharma and biotech companies access to expert-level talent, including Medical Science Liaisons, Medical Directors, Clinical Specialists, and Project Managers on a flexible, as-needed basis. Rather than committing to full-time employees, companies can engage these professionals during high-impact phases such as clinical development and trial design, regulatory submission, pre-launch planning, and post-launch scientific engagement.
Contribution levels of individual BioLogic team members can be modulated in real time to ensure overall alignment with evolving needs and priorities. When timelines shift or demand slows down, resources can be scaled down, ensuring cost control without sacrificing expertise.
Why Partner with BioLogic Pharma Solutions
At BioLogic Pharma Solutions, we help companies remain lean, agile, and focused. Some common cases include entering a new therapeutic area, preparing for launch, and bridging internal gaps. In each case, our model results in faster progress, smarter decisions, and strategic clarity, without the operational burden of building full-time teams too soon.
We are the first medical affairs consulting firm to specialize in and offer a fractional medical team. Our cross-functional teams bring large pharma experience and agility to all our clients. Whether preparing for the first launch, or navigating a critical growth phase, we provide strategic Medical Affairs support when our clients need it.
Contact us today to elevate your Medical Affairs strategy.
Related Articles
July 21, 2025
November 13, 2024
Interested in our services?
We’ll be in touch to explore how our Fractional Medical Affairs™ model can support your success.